Caraco Pharmaceutical/Sun Pharma
On February 22, 2011, Caraco Pharmaceutical Laboratories, Ltd. (AMEX: CPD) has entered into a merger agreement with Sun Pharmaceutical Industries Limited, Sun Pharma Global, Inc, a wholly-owned subsidiary of Sun Pharma organized under the laws of the British Virgin Islands (Sun Global) and a newly-formed, indirect wholly-owned subsidiary of Sun Pharma incorporated in Michigan.
Under the agreement, Caraco shareholders will receive $5.25 per share in cash.
The Independent Committee was advised by William Blair & Company, L.L.C. as its independent financial advisor and Carrington Coleman as its independent legal counsel.
Under the agreement, Caraco shareholders will receive $5.25 per share in cash.
The Independent Committee was advised by William Blair & Company, L.L.C. as its independent financial advisor and Carrington Coleman as its independent legal counsel.
